학술논문
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects
Document Type
Article
Author
Source
In: British Journal of Clinical Pharmacology . (British Journal of Clinical Pharmacology, May 2018, 84(5):876-887)
Subject
Language
English
ISSN
13652125
03065251
03065251